Literature DB >> 11506244

Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care.

E J Lewis1, M M Schwartz, S M Korbet.   

Abstract

The histopathology of severe lupus glomerulonephritis comprises distinct patterns of injury which were initially defined by the World Health Organization Classification of 1982 as focal and segmental glomerulonephritis (category III), diffuse proliferative glomerulonephritis (category IV) and complex membranous glomerulonephritis (categories Vc, Vd). It is assumed that the morphologic abnormalities demonstrated in this classification represent distinctive differences in the mediation of the immune response which leads to a specific type of glomerular inflammation. In 1995 the World Health Organizational committee recommended a change in categorization of focal and segmental glomerulonephritis (class III) and diffuse proliferative glomerulonephritis (class IV), which would overlook the morphological differences between these categories and treat them as a continuum, recommending that biopsies classified as focal and segmental glomerulonephritis (category III) with involvement of > or =50% of glomeruli be included into the diffuse proliferative glomerulonephritis category (category IV). Since the classification of severe lupus nephritis has significant impact on prognosis and the therapeutic approach to patients with this disease, it is the purpose of this review to critically re-examine the existing classification based on new insights into differences in morphologic features and long-term outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11506244

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

Review 1.  Treatment of severe proliferative lupus nephritis: the current state.

Authors:  C C Mok; R W S Wong; K N Lai
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Renal involvement in childhood-onset systemic lupus erythematosus in Egypt.

Authors:  Samia Salah-El-Din Mahmoud; Hafez Mahmoud Bazaraa; Hala Mohamed Lotfy; Doaa Mohamed Abd-El-Aziz
Journal:  Rheumatol Int       Date:  2010-07-24       Impact factor: 2.631

3.  Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

Authors:  Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Daniel J Birmingham; Brad H Rovin
Journal:  Theor Biol Med Model       Date:  2010-05-17       Impact factor: 2.432

4.  Relationship between interstitial CD34 positive cells and active phase of lupus nephritis.

Authors:  Farahnaz Noroozinia; Leila Mahmoudzadeh; Farzaneh Hosseini Gharalari; Khadijeh Makhdoomi; Ata Abbasi
Journal:  Eur J Rheumatol       Date:  2018-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.